Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/24888
Type
ArticleCopyright
Restricted access
Embargo date
2030-01-01
Collections
- IOC - Artigos de Periódicos [12341]
Metadata
Show full item record
LINEAGE-SPECIFIC REAL-TIME RT-PCR FOR YELLOW FEVER VIRUS OUTBREAK SURVEILLANCE, BRAZIL
Author
Affilliation
University of Bonn Medical Centre. Bonn, Germany.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
TIB MOLBIOL. Syntheselabor GmbH. Berlin, Germany.
Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin., Humboldt- Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Germany.
Aix-Marseille University. Marseille, France.
Aix-Marseille University. Marseille, France / Institut Hospitalo Universitaire Méditerranée-Infection. Marseille. France.
Aix-Marseille University. Marseille, France / Institut Hospitalo Universitaire Méditerranée-Infection. Marseille. France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
University of Bonn Medical Centre. Bonn, Germany.
German Centre for Infection Research (DZIF). Germany / Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin., Humboldt- Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Germany.
TIB MOLBIOL Syntheselabor GmbH, Berlin, Germany.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
German Centre for Infection Research (DZIF). Germany / Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin., Humboldt- Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Germany.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
TIB MOLBIOL. Syntheselabor GmbH. Berlin, Germany.
Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin., Humboldt- Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Germany.
Aix-Marseille University. Marseille, France.
Aix-Marseille University. Marseille, France / Institut Hospitalo Universitaire Méditerranée-Infection. Marseille. France.
Aix-Marseille University. Marseille, France / Institut Hospitalo Universitaire Méditerranée-Infection. Marseille. France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
University of Bonn Medical Centre. Bonn, Germany.
German Centre for Infection Research (DZIF). Germany / Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin., Humboldt- Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Germany.
TIB MOLBIOL Syntheselabor GmbH, Berlin, Germany.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
German Centre for Infection Research (DZIF). Germany / Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin., Humboldt- Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Germany.
Abstract
The current yellow fever outbreak in Brazil prompted widespread yellow fever virus (YFV) vaccination campaigns, imposing a responsibility to distinguish between vaccine- and wild-type YFV-associated disease. We developed novel multiplex real-time reverse transcription PCRs that differentiate between vaccine and American wild-type YFV. We validated these highly specific and sensitive assays in an outbreak setting.
Share